Inhibition of the Expression of Inducible NO Synthase by Neuroactive Amino Acid Derivatives Phenibut and Glufimet In Vitro and Ex Vivo


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

The effects of glufimet and phenibut (glutamic acid and GABA derivatives, respectively) on concentration of inducible NO synthase and cGMP in LPS-activated mouse peritoneal macrophages and on NO end products in their culture medium were examined in vitro and ex vivo. Addition of LPS into culture medium elevated concentration of NO metabolites in this medium and increased concentration of inducible NO synthase and cGMP in the lysates of peritoneal macrophages, whereas incubation of the cells with examined agents applied at concentration of 10—5 M diminished these indices. Similar results were obtained with intraperitoneal injection of LPS, glufimet, and phenibut. In culture medium containing peritoneal macrophages from the mice injected with LPS (100 μg/kg), the concentrations of inducible NO synthase and cGMP as well as the total concentration of nitrite and nitrate ions increased, whereas in culture medium with the cells from LPS-exposed mice treated with glufimet (28.7 mg/kg) and phenibut (50 mg/kg) these indices significantly decreased.

Sobre autores

A. Borisov

Department of Pharmacology and Biopharmacia, Faculty of Continuing Medical Education, Volgograd State Medical University, Ministry of Health of the Russian Federation

Email: igor.prokofiev@mail.ru
Rússia, Moscow

I. Prokofiev

Department of Pharmacology and Biopharmacia, Faculty of Continuing Medical Education, Volgograd State Medical University, Ministry of Health of the Russian Federation

Autor responsável pela correspondência
Email: igor.prokofiev@mail.ru
Rússia, Moscow

I. Mokrousov

Department of Pharmacology and Biopharmacia, Faculty of Continuing Medical Education, Volgograd State Medical University, Ministry of Health of the Russian Federation

Email: igor.prokofiev@mail.ru
Rússia, Moscow

V. Perfilova

Department of Pharmacology and Biopharmacia, Faculty of Continuing Medical Education, Volgograd State Medical University, Ministry of Health of the Russian Federation

Email: igor.prokofiev@mail.ru
Rússia, Moscow

I. Tyurenkov

Department of Pharmacology and Biopharmacia, Faculty of Continuing Medical Education, Volgograd State Medical University, Ministry of Health of the Russian Federation

Email: igor.prokofiev@mail.ru
Rússia, Moscow


Declaração de direitos autorais © Springer Science+Business Media, LLC, part of Springer Nature, 2017

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies